Global Cancer Technology
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
16776 Bernardo Center Dr Ste 203, San Di...Phone Number
(858) 451-6173Revenue
<$5 MillionIndustry
About Global Cancer Technology
Global Cancer Technology Org Chart
Is Global Cancer Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Global Cancer Technology recently announced quarterly report
Funding: Get notified immidiatlly once Global Cancer Technology has new funding data
Click to see if Global Cancer Technology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Global Cancer Technology launches new products
Global Cancer Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Global Cancer Technology has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Global Cancer Technology
Check out if Global Cancer Technology is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Global Cancer Technology
Compare insights from companies similar to Global Cancer Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Global Cancer Technology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Global Cancer Technology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Global Cancer Technology.
Global Cancer Technology Tech Stack
A closer look at the technologies used by Global Cancer Technology
Global Cancer Technology News & Media
THE UNIVERSITY OF COLORADO CONCLUDES SEMAPHORIN 7A IN VIVO STUDY WITH GLOBAL CANCER TECHNOLOGY’S DRUG, GCT-007
THE LABORATORY OF DR. TRACI LYONS AT THE UNIVERSITY SHOWS THAT GCT-007 CAN SLOW SEMAPHORIN 7A-DEPENDENT TUMOR GROWTH IN PRECLINICAL MODELS OF BREAST CANCER SAN DIEGO, CALIFORNIA, UNITED STATES, June 4, 2023 /EINPresswire.com/ -- Global Cancer Technology …Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. [PR.com]Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. [PR.com]Mayor Johnson Proclaims International Brain Tumor Awareness Week, Local Researchers Pave the Way to a Treatment
DALLAS, Oct. 29, 2021 /PRNewswire/ -- In recognition of the local strides being made in the fight against brain tumors, Mayor Eric Johnson has designated October 30th thru November 6th, 2021 as International Brain Tumor Awareness Week in the City of Dallas. Local researchers from Global...
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Global Cancer Technology
Global Cancer Technology is a biopharma company focused on developing innovative treatments for various cancers, particularly glioblastoma. They are working on a small molecule PI3K inhibitor that can effectively cross the blood-brain barrier and has shown promising results in preclinical studies. The company aims to improve cancer treatment outcom... Read More